HeartBeam (BEAT) announced its regulatory strategy following receipt of a Not Substantially Equivalent, or NSE, decision on the company’s 510(k) ...
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application ...
A 94-year-old female with history of hypertension, chronic kidney disease, and hyperlipidemia presents to the emergency ...
The Charge 6 is claimed to give you the most accurate data ever built into a Fitbit tracker. If you want many of the features ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback